Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM.
Description | Wortmannin is the first described PI3K inhibitor with IC50 of 3 nM, with little selectivity within the PI3K family. Also blocks autophagosome formation and potently inhibits DNA-PK/ATM with IC50 of 16 nM and 150 nM. |
Targets&IC50 | ATM:150 nM, DNA-PK:16 nM, PI3K:3 nM |
In vitro | Mitomycin C, by inducing DNA interstrand crosslinks, physically blocks DNA replication, recombination, and RNA transcription. [1] Mitomycin C potentiates TRAIL-induced apoptosis in HCT116 (p53-/-) colon cancer cells and sensitizes TRAIL-resistant colon cancer cells HT-29 to the cytokine by through JNK-independent upregulation of death receptors. [2] In different human cancer cell lines, such OVCAR-5 (ovary), HT-29 (colon), SK-N-MC (neuroblastoma), HEP-2 (liver), COLO-205 (colon), NIH-OVCAR-3 (ovary) and A-549 (lung) cells, Mitomycin C shows cytotoxic activity. [3] |
Synonyms | KY12420, Antibiotic, SL2052, PI3K, KY 12420, inhibit, Wortmannin, KY-12420, Autophagy, Polo-like Kinase (PLK), SL 2052, SL-2052, Phosphoinositide 3-kinase, Inhibitor |
Molecular Weight | 428.437 |
Formula | C23H24O8 |
CAS No. | 19545-26-7 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
Ethanol: 2.1 mg/mL (5 mM)), with gentle warming
DMSO: 21.4 mg/mL (50 mM)
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.